Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
OKYO Pharma Limited Sponsored ADR (OKYO) Normalized Income after Taxes data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.64M |
|
$0.00M |
|
$0.00M |
|
$4.64M |
|
$8.06M |
|
-- |
|
-- |
|
$8.06M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
38.45M |
|
| Cash Flow Statement Financials | |
$-1.53M |
|
-- |
|
$4.32M |
|
$1.56M |
|
$4.22M |
|
$2.66M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|